Showing 381-390 of 4262 results for "".
Update On the Use of Spironolactone to Treat Adult Female Acne
https://practicaldermatology.com/topics/general-topics/update-on-the-use-of-spironolactone-to-treat-adult-female-acne/20917/There is a role for spironolactone in some adult female acne patients.Cultural Competence in Dermatology
https://practicaldermatology.com/topics/skin-of-color/cultural-competence-in-dermatology/23591/Acknowledging cultural differences, keeping an open mind, and showing empathy go a long way toward improving the patient’s care experience.Contemporary African-American Hair Care Practices
https://practicaldermatology.com/topics/practice-management/contemporary-african-american-hair-care-practices/21176/As trends and sensibilities regarding hair practices shift, it is important for physicians to understand the needs of African-American patients in order to appropriately discuss healthy hair habits.Fillers for the Décolletage Area
https://practicaldermatology.com/topics/practice-management/fillers-for-the-dcolletage-area/21113/Fillers offer patients an alternative to device-based interventions for chest rejuvenation.o, MDComorbidities in Psoriasis
https://practicaldermatology.com/topics/psoriasis/comorbidities-in-psoriasis/54453/Psoriasis is associated with numerous systemic comorbidities, many of which are linked through IL-17/IL-23-mediated inflammation. Comorbid conditions such as diabetes, IBD, metabolic syndrome, and PsA are not only more prevalent but often more severe in psoriasis patients, highlighting the importan"Psleep": Psoriasis and Sleep
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/psleep-psoriasis-and-sleep/29075/The “invisible” impacts of psoriasis are those not directly seen on examination. These include itch, pain, fatigue and sleep dysfunction, which may be improved by our systemic therapies. However, there is a gap between the patients’ reporting of these experienced invisible impacts and their physiciaFrom SDPA: JAKs, Black Boxes, and What It All Means
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-jaks-black-boxes-and-what-it-all-means/26286/Practitioners shouldn’t fear Janus kinase (JAK) inhibitors for their patients when appropriate, according to a wide-ranging expert chat at the 2024 SDPA Annual Summer Conference in San Diego. The conversation featured Matthew Zirwas, MD, a dermatologist with DOCS Dermatology, and Amy Spizuoco, DO, FPractical Approaches to Diagnosing and Treating Hair Loss
https://practicaldermatology.com/topics/hair-nails/practical-approaches-to-diagnosing-and-treating-hair-loss/23969/Hair loss is a common presenting issue for many dermatology patients and a daunting diagnosis for the dermatologist. Assessing hair issues is like examining tree rings; you are assessing the future by looking at the past. This is particularly challenging since the hair available for examination at tMore Than Skin Deep: Assessing the Full Impact of Psoriasis Using the Cumulative Life Course Impairment Rating
https://practicaldermatology.com/topics/psoriasis/more-than-skin-deep-assessing-the-full-impact-of-psoriasis-using-the-cumulative-life-course-impairment-rating/23938/Doctors have a useful new metric for evaluating the cumulative impact of psoriasis on patient quality of life.Optimizing Dermatology Office Visits With Children and Families
https://practicaldermatology.com/topics/practice-management/optimizing-dermatology-office-visits-with-children-and-families/23897/Different ages call for different approaches when seeing pediatric patients.